Valvular Atrial Fibrillation (VAF) is a specific subtype of atrial fibrillation characterized by the presence of significant heart valve disease. In individuals with VAF, irregular and often rapid heartbeats occur due to abnormal electrical signals in the atria, the upper chambers of the heart. The presence of valvular heart disease, such as mitral stenosis or a mechanical heart valve, increases the risk of developing VAF. Managing VAF poses unique challenges, as treatment strategies need to consider both the atrial fibrillation and the underlying valvular pathology. Healthcare professionals typically tailor their approach based on factors like the severity of the valve disease, overall health status, and individual patient considerations. Close monitoring and a collaborative, multidisciplinary approach are essential in addressing the complexities of Valvular Atrial Fibrillation.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China